Page last updated: 2024-10-30

lansoprazole and Stomatitis

lansoprazole has been researched along with Stomatitis in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Stomatitis: INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.

Research Excerpts

ExcerptRelevanceReference
"Lansoprazole is a potent antisecretory drug also possessing anti-Helicobacter pylori activity in vitro."6.68Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease. ( Bang, CJ; Berstad, A; Hatlebakk, JG; Hausken, T; Nesje, LB, 1995)
"Lansoprazole is a potent antisecretory drug also possessing anti-Helicobacter pylori activity in vitro."2.68Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease. ( Bang, CJ; Berstad, A; Hatlebakk, JG; Hausken, T; Nesje, LB, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatlebakk, JG1
Nesje, LB1
Hausken, T1
Bang, CJ1
Berstad, A1
Greco, S1
Mazzaglia, G1
Caputi, AP1
Pagliaro, L1

Trials

1 trial available for lansoprazole and Stomatitis

ArticleYear
Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease.
    Scandinavian journal of gastroenterology, 1995, Volume: 30, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Amoxicillin; Anti-Ulcer Agents; Capsu

1995

Other Studies

1 other study available for lansoprazole and Stomatitis

ArticleYear
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics.
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-

1997